NervGen Pharma Corp. (NGEN)
1.43
+0.01
(+0.70%)
USD |
NASDAQ |
Oct 23, 16:00
1.42
-0.01
(-0.70%)
After-Hours: 20:00
NervGen Pharma Total Return Level : 1.43 for Oct. 23, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.43 |
| October 22, 2026 | 1.42 |
| October 21, 2026 | 1.50 |
| October 20, 2026 | 1.54 |
| October 19, 2026 | 1.54 |
| October 16, 2026 | 1.59 |
| October 15, 2026 | 1.62 |
| October 14, 2026 | 1.565 |
| October 13, 2026 | 1.63 |
| October 12, 2026 | 1.73 |
| October 09, 2026 | 1.73 |
| October 08, 2026 | 1.75 |
| October 07, 2026 | 1.74 |
| October 06, 2026 | 1.75 |
| October 05, 2026 | 1.81 |
| October 02, 2026 | 1.78 |
| October 01, 2026 | 1.76 |
| September 30, 2026 | 1.91 |
| September 29, 2026 | 1.92 |
| September 28, 2026 | 1.88 |
| September 25, 2026 | 1.94 |
| September 24, 2026 | 2.02 |
| September 23, 2026 | 1.96 |
| September 22, 2026 | 2.065 |
| September 21, 2026 | 1.99 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.05 |
| September 17, 2026 | 2.27 |
| September 16, 2026 | 2.13 |
| September 15, 2026 | 2.14 |
| September 14, 2026 | 2.195 |
| September 11, 2026 | 2.185 |
| September 10, 2026 | 2.16 |
| September 09, 2026 | 2.13 |
| September 08, 2026 | 2.19 |
| September 04, 2026 | 2.33 |
| September 03, 2026 | 2.32 |
| September 02, 2026 | 2.33 |
| September 01, 2026 | 2.32 |
| August 31, 2026 | 2.21 |
| August 28, 2026 | 2.28 |
| August 27, 2026 | 2.335 |
| August 26, 2026 | 2.21 |
| August 25, 2026 | 2.08 |
| August 24, 2026 | 2.00 |
| August 21, 2026 | 1.86 |
| August 20, 2026 | 1.76 |
| August 19, 2026 | 1.75 |
| August 18, 2026 | 1.71 |
| August 17, 2026 | 1.68 |
| August 14, 2026 | 1.735 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| InMed Pharmaceuticals, Inc. | 1.44 |
| Milestone Pharmaceuticals, Inc. | 0.6482 |
| Appili Therapeutics, Inc. | 0.0068 |
| Clearmind Medicine, Inc. | 5.87 |
| Lexaria Bioscience Corp. | 3.08 |